New York, NY, September, 19, 2022 — Zenysis Technologies, Inc. (Zenysis) announced today a US $5 million pledge to the Global Fund toward its seventh replenishment. The pledge consists of in-kind support in the form of technology and services that can help the Global Fund transform the impact of every dollar it invests in health programs around the world.
“We are proud to continue to support the Global Fund’s mission to end AIDS, tuberculosis and malaria,” said Jonathan Stambolis, CEO, Zenysis. “We believe the private sector has a critical role to play, and we are committed to doing our part to serve the communities most affected by these diseases worldwide,” he added.
Zenysis is a global technology company that helps governments and international organizations unleash the power of their data to save lives. Zenysis will collaborate closely with the Global Fund to identify and provide its data integration and advanced analytics expertise to relevant in-country partners and implementers.
Stambolis announced Zenysis’ pledge at a convening of private sector innovation and technology partners hosted by the Global Fund in New York City as part of its seventh replenishment programming. Stambolis also spoke on a panel on driving equitable health through digital innovation at the event.
Zenysis’ pledge for 2023-2025 is supported by the Steele Foundation for Hope, the lead investor in the company’s recent Series B financing.
About Zenysis Technologies: Zenysis is a big data startup that builds the software governments need to meet some of the most urgent challenges facing humanity. Our software helps public and private institutions harness the power of their data to improve people’s lives. Learn more at www.zenysis.com.
